Guorong Han

1.6k total citations · 1 hit paper
28 papers, 1.0k citations indexed

About

Guorong Han is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Guorong Han has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 17 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Guorong Han's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (11 papers). Guorong Han is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (11 papers). Guorong Han collaborates with scholars based in China, United States and Germany. Guorong Han's co-authors include Calvin Q. Pan, Xin Yue, Hongxiu Jiang, Wei Zhao, Huaibin Zou, Shuqin Zhang, Wenjing Zhao, Huaihong Zhang, Erhei Dai and Yuming Wang and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Gut.

In The Last Decade

Guorong Han

26 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

2016 386 citations Calvin Q. Pan, Zhongping Duan et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Guorong Han

Since Specialization

Citations

This map shows the geographic impact of Guorong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guorong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guorong Han more than expected).

Fields of papers citing papers by Guorong Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guorong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guorong Han. The network helps show where Guorong Han may publish in the future.

Co-authorship network of co-authors of Guorong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Guorong Han. A scholar is included among the top collaborators of Guorong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guorong Han. Guorong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China 2024 ·Nature Medicine ·Xueru Yin, Wei Wang, Hui Chen, Qing Mao, Guorong Han, (unknown), (unknown), Yunfei Gao, Jie Jin, T. Sun, (unknown), Hua Zhang, Baijun Li, Chongyang Duan, Fuqiang Cui, Weiming Tang, Polin Chan, Zhihua Liu, Jinlin Hou, (unknown)	17
2	Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B 2024 ·Human Cell ·(unknown), (unknown), Ling Jing, Qunying Wu, Guorong Han, (unknown)	2
3	Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation 2024 ·Journal of Ovarian Research ·(unknown), (unknown), Rui Gu, Yan Tang, Guorong Han, (unknown)	6
4	Staging and clinical characteristics of pregnant women with chronic hepatitis B virus infection: A retrospective cohort study from Nanjing, China 2023 ·Journal of obstetrics and gynaecology research ·(unknown), Guorong Han, Ping Zhang, Jing Xu, Chao Chen, Hongxiu Jiang, (unknown), (unknown), (unknown)	2
5	The relationship of maternal hepatitis B e antigen and response to vaccination of infants born to women with chronic infection 2023 ·BMC Pregnancy and Childbirth ·Hongxiu Jiang, Chao Chen, (unknown), (unknown), Yan Chen, Guorong Han, (unknown), (unknown), Minkai Cao	2
6	Efficacy and Long-term Safety of Telbivudine Usage During Second or Third Trimester in Hepatitis B Surface Antigen Positive Mothers With High Viral Load 2022 ·Journal of Clinical Gastroenterology ·Hongxiu Jiang, (unknown), Chao Chen, (unknown), Guorong Han	0
7	Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy 2022 ·European Journal of Histochemistry ·Minkai Cao, (unknown), Hongxiu Jiang, (unknown), Chao Chen, Guorong Han	6
8	Exosomal Circular RNA hsa_circ_0046060 of Umbilical Cord Mesenchymal Stromal Cell Ameliorates Glucose Metabolism and Insulin Resistance in Gestational Diabetes Mellitus via the miR-338-3p/G6PC2 Axis 2022 ·International Journal of Endocrinology ·Minkai Cao, (unknown), Jingjing Zhang, (unknown), (unknown), Chao Chen, Guorong Han, (unknown), Juan Wen	8
9	Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method 2021 ·Frontiers in Pharmacology ·Na Yang, (unknown), (unknown), Jun He, Yan Chen, Chao Chen, (unknown), Jiajia Ge, Min Wang, Tianqi Zhang, (unknown), Huaijun Zhu, Guorong Han	5
10	A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01) 2020 ·Journal of Clinical and Translational Hepatology ·Xueru Yin, Guorong Han, (unknown), (unknown), Wenjun Zhang, Yunfei Gao, Mei Zhong, Xiaolan Wang, (unknown), (unknown), (unknown), (unknown), Zhihong Liu, Polin Chan, Marc Bulterys, Fuqiang Cui, Hui Zhuang, Zhihua Liu, Jinlin Hou	12
11	Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus 2018 ·Clinical Gastroenterology and Hepatology ·Jinlin Hou, Fuqiang Cui, Yang Ding, Xiaoguang Dou, Zhongping Duan, Guorong Han, Jidong Jia, Qing Mao, Jie Li, (unknown), Zhihua Liu, Lai Wei, Qing Xie, (unknown), Hua Zhang, Hui Zhuang	47
12	Survival by pattern of tumor progression during prior sorafenib (SOR) treatment in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial comparing second-line treatment with regorafenib (REG) or placebo 2017 ·Zeitschrift für Gastroenterologie ·Peter R. Galle, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, G. Bodoky, Marc Pracht, Osamu Yokosuka, René Gerolami, (unknown), (unknown), (unknown), Tianqiang Song, (unknown), Isabelle Ollivier‐Hourmand, Masatoshi Kudo, (unknown), Gudrun Meinhardt, Guorong Han, Jordi Bruix	1
13	Tenofovir to Prevent Hepatitis B Transmission in Mothers With High Viral Load 2016 ·Obstetrical & Gynecological Survey ·Calvin Q. Pan, Zhongping Duan, Erhei Dai, Shuqin Zhang, Guorong Han, Yuming Wang, Huaihong Zhang, Huaibin Zou, (unknown), Wenjing Zhao, Hongxiu Jiang	3
14	Serum 25-hydroxyvitamin D status in pregnant women with chronic hepatitis B virus infection 2016 ·The Journal of Infection in Developing Countries ·Xueren Gao, (unknown), Wenjun Wang, Guorong Han, Jianqiong Zhang	6
15	Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load breakdown → 2016 ·New England Journal of Medicine ·Calvin Q. Pan, Zhongping Duan, Erhei Dai, Shuqin Zhang, Guorong Han, Yuming Wang, Huaihong Zhang, Huaibin Zou, (unknown), Wenjing Zhao, Hongxiu Jiang	386
16	FEN1 -69G>A and 4150G>T polymorphisms and cancer risk in Chinese population 2014 ·Scientific Reports ·Xueren Gao, Shulong Zhang, Yongfeng Yang, Guorong Han	10
17	Management of chronic hepatitis B in pregnancy 2012 ·World Journal of Gastroenterology ·Guorong Han	36
18	Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B 2012 ·Clinical Gastroenterology and Hepatology ·Calvin Q. Pan, Guorong Han, (unknown), Wei Zhao, (unknown), (unknown), Xin Yue, (unknown)	122
19	[Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B]. 2012 ·PubMed ·Hongxiu Jiang, Guorong Han, (unknown), Ying Ji	8
20	A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection 2011 ·Journal of Hepatology ·Guorong Han, Minkai Cao, Wei Zhao, Hongxiu Jiang, (unknown), Shu‐Fen Bai, Xin Yue, (unknown), (unknown), (unknown)	260

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact